Silverarc Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	–	–	98
2025 Q3	–	Hold	0	–	–	–	100
2024 Q1	–	Sell	-16,360	Closed	-$3.6M	–	97
2023 Q4	$3.6M	Sell	16,360 -15,064	-48%	-$3.47M	1.11%	36
2023 Q3	$7.1M	Buy	31,424 +1,395	+5%	+$321K	2.64%	14
2023 Q2	$6.63M	Buy	30,029 +11,451	+62%	+$2.54M	2.24%	15
2023 Q1	$4.16M	Buy	18,578 +2,530	+16%	+$624K	1.87%	24
2022 Q4	$4.46M	Buy	16,048 +5,352	+50%	+$1.35M	1.54%	30
2022 Q3	$2.24M	Sell	10,696 -5,531	-34%	-$1.24M	0.95%	43
2022 Q2	$3.82M	Buy	16,227 +1,391	+9%	+$283K	1.79%	30
2022 Q1	$2.66K	Buy	14,836 +285	+2%	+$54.3K	1.26%	23
2021 Q4	$3.14M	Sell	14,551 -6,638	-31%	-$1.3M	1.41%	26
2021 Q3	$3.91M	Buy	21,189 +5,900	+39%	+$1.16M	2.27%	13
2021 Q2	$2.74K	Buy	15,289 +9,925	+185%	+$1.89M	1.34%	28
2021 Q1	$897K	Hold	5,364	–	–	0.5%	56
2020 Q4	$814K	Buy	+5,364	New	+$704K	0.5%	55